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1. Additional figures 
 
Figure S1. 1H NMR spectra of compounds 2a and 2b in aqueous potassium phosphate buffer (pH 8) after 12 hours 
at the indicated temperature. *Signals associated with decomposition products. 
 
 
Figure S2. Formation of product 3a at different pH (solid line) and accompanying formation of hydrolysis 
byproduct 4 (dashed line). See Section 2.9 for experimental details. 
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2. Procedures for enzyme expression and characterization 
2.1 Cloning, expression, and purification of TrpB variants 
The gene encoding Pf(β-Me) was previously cloned into pET22(b)+ with a C-terminal His-tag.1 Protein 
expression of the variants was carried out in Escherichia coli BL21 E. cloni Express cells (Lucigen) by inoculating 5 
mL of Lysogeny Broth containing 100 µg/mL carbenicillin (LBcarb) with a single colony and incubating this pre-
culture overnight at 37 °C and 230 rpm. The overnight cultures were used to inoculate 500 mL of Terrific Broth 
containing 100 µg/mL carbenicillin (TBcarb). The expression cultures were shaken at 37 °C and 230 rpm for ~3 h, at 
which point the OD600 was 0.6–0.8. The cultures were chilled on ice for >30 min and then induced by the addition of 
1 M aq. isopropyl β-D-thiogalactopyranoside (IPTG, 500 µL, final concentration of 1 mM). Expression of the 
variants took place at 230 rpm and 20 °C for another 20 h. The cultures were centrifuged at 5,000×g and 4 °C for 5 
minutes. The cell pellets were decanted, then frozen and stored at –20 °C until further use. 
For protein purification, cells were thawed, then re-suspended in potassium phosphate buffer (25 mM, pH 8) that 
contained 20 mM imidazole, 100 mM NaCl, 400 µM PLP, 1 mg/mL of hen egg white lysozyme (HEWL, Sigma 
Aldrich), and 0.1 mg/mL of bovine pancreas DNase I. BugBuster (Novagen) was added, then the mixture was 
vortexed to suspend the pellet. The suspension was shaken at 37 °C and 230 rpm for 15 min, then centrifuged at 
5000×g and 4 °C for 10 minutes. Without decanting, the cell lysate was immersed in a water bath at 75 °C. After 30 
minutes, the suspension was centrifuged (15,000×g and 4 °C for 15 minutes). The supernatant was purified using a 
1-mL HisTrap HP column with an AKTA purifier FPLC system (GE Healthcare) and a linear gradient from buffer 
A (25 mM potassium phosphate, 20 mM imidazole, 100 mM NaCl, pH 8) to buffer B (25 mM potassium phosphate, 
500 mM imidazole, 100 mM NaCl, pH 8) over 10 volumes. Proteins eluted at approximately 140 mM imidazole. 
Purified proteins were dialyzed into potassium phosphate buffer (50 mM, pH 8), then flash-frozen in liquid N2 and 
stored at –80 °C until further use. Protein concentrations were determined via the Bradford assay (Bio-Rad). 
 
2.2 Construction of site-saturation mutagenesis libraries 
PCR was conducted using Phusion polymerase (New England Biolabs) according to the standard protocol. For the 
given site of mutagenesis, three primers were designed containing codons NDT (encoding for Ile, Asn, Ser, Gly, 
Asp, Val, Arg, His, Leu, Phe, Tyr, and Cys), VHG (encoding for Met, Thr, Lys, Glu, Ala, Val, Gln, Pro, and Leu), 
and TGG (Trp), respectively, thereby including all 20 natural amino acids. These three primers were mixed in a ratio 
12:9:1 according to the previously described protocol.2 Then, the plasmid was constructed by site-directed 
mutagenesis by overlap extension (SOE) PCR using a plasmid that contained the parent gene in the pET22(b)+ 
vector as template. The linear plasmid was digested with DpnI (1 µL per 50 µL PCR reaction, incubated at 37 °C for 
2 hours), purified by preparative agarose gel, then cyclized via the Gibson method.3 
 
2.3 Construction of random recombination libraries 
These libraries were constructed in an analogous manner to the site-saturation libraries, using primers that coded 
for both the native residue and the mutation. The mutant genes were first constructed as fragments, which were 
purified by preparative agarose gel, then assembled into a contiguous gene using primers that corresponded to the 
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NdeI and XhoI sites of the pET22(b)+ vector (GAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATG 
and GCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAG, respectively). After a final purification by agarose 
gel, the assembled gene was cloned into an empty pET22(b)+ vector between restriction sites NdeI and XhoI using 
the Gibson method.3 
 
2.4 Transformation of BL21 E. coli cells 
In preparation, SOC medium, 50 µL aliquots of electrocompetent BL21 E. coli cells, and electroporation cuvettes 
were chilled in ice. The plasmid (1 µL) was added to the cells, which were then transferred to a sterile 
electroporation cuvette. An electric potential was applied with a Gene Pulser Xcell (2.5 kV, 25 µF, 200 Ω). Then, 
SOC medium (750 µL) was immediately added and the cuvette was shaken at 37 °C and 230 rpm. After 45 min, 
aliquots of cell suspension were plated onto LBamp agar plates. The plates were incubated overnight at 37 °C, then 
stored at 4 °C until further use. 
 
2.5 Library expression and screening 
BL21 E. cloni Express cells carrying parent and variant plasmids were grown in 96-well deep-well plates (300 
µL/well TBamp) at 37 °C and 80% humidity. After shaking at 250 rpm overnight, 20 µL of the overnight cultures 
were transferred to new deep-well plates containing 630 µL/well TBamp, which were allowed to grow at 37 °C and 
80% humidity. After shaking at 250 rpm for 3 h, the plates were chilled on ice for 30 min, then induced by the 
addition of IPTG in TBamp (1 mM final concentration). The cultures were shaken at 250 rpm and 20 °C. After 20 
hours, the cultures were centrifuged at 4,000×g for 10 min. The cell pellets were frozen at –30 °C for a minimum of 
2 hours. For screening, cells were thawed at room temperature and then lysed by the addition of 400 µL/well of 
potassium phosphate buffer (50 mM, pH 8.0), with 1 mg/mL HEWL, 0.1 mg/mL DNase I, 40 µM PLP, and 2 mM 
MgCl2. The plates were incubated for 1 h at 37 °C, then transferred to a water bath equilibrated to 75 °C. After 30 
min, the plates were chilled in ice, then centrifuged at 5,000×g and 4°C for 20 min. 
The reactions were performed in 96-well deep-well plates. In general, each well was charged with the nitroalkane 
substrate as a solution in DMSO (10 µL/well). Then, a solution of serine in potassium phosphate buffer (50 mM, pH 
8.0, 140 µL) was added. Finally, the enzymes were added as heat-treated lysate (50 µL), such that the total volume 
in the wells was 200 µL. All libraries were screened with 10 µmol of nitroalkane and 10 µmol of serine. 
The plates were sealed with Teflon sealing mats, then immersed in a water bath equilibrated to 50 °C. After ~12 
hours, the plates were chilled in ice and briefly centrifuged (5,000×g, 5 min) to settle the reaction contents to the 
bottom of the wells. The reactions were then processed depending on the assay being used. 
For analysis using a UV-visible light plate reader, each well was charged with 500 µL of ethyl acetate and 900 µL 
of aq. 1 M HCl. The plates were again sealed with Teflon sealing mats, then shaken vigorously to dissolve all 
precipitates and partition the product and substrate between the aqueous and organic phases, respectively. The plates 
were again centrifuged (5,000×g, 2 min), then 200 µL of the aqueous phase were transferred to 96-well UV-vis 
assay plates. The activity of each well was determined by measuring the absorption at 260 nm. 
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For analysis by UHPLC/MS, the reactions were diluted with 800 µL of 1:1 CH3CN/H2O that contained 1-
naphthylamine (0.1 mg/mL). The plates were centrifuged at 5,000×g and 20 °C for 15 minutes, then the supernatants 
were transferred to a fresh assay plate. Each well was analyzed with a C-18 silica column (4.6 × 50 mm) using 
acetonitrile/water (0.1% acetic acid by volume): 5% to 95% acetonitrile over 2 minutes, 95% for 1 min; 1 mL/min. 
The activity was approximated by dividing the integration of product ion with that of 1-naphthylamine. 
 
2.6 Small-scale reactions with heat-treated lysate (data in Figure 2) 
The enzyme was expressed as a 5-mL culture in TBamp according to the procedure in Section 2.1. The cell pellet 
was suspended in 400 µL potassium phosphate buffer (50 mM, pH 8) that contained 1 mg/mL HEWL, 0.1 mg/mL 
DNase I, and 200 µM PLP. BugBuster was added, then the suspension was shaken at 37 °C and 230 rpm. After 15 
minutes, the suspension was chilled in ice, then centrifuged at 5,000×g and 4 °C (10 minutes). The supernatant was 
transferred to a 1.5-mL Eppendorf tube, then heated to 75 °C. After 30 minutes, the suspensions were chilled in ice, 
then centrifuged at 20,000×g and 4 °C (10 minutes). The concentration of enzyme in the lysate was estimated using 
the Bradford assay, and then adjusted to 100 µM. 
A 2-mL HPLC vial was charged with nitroalkane as a 1 M solution in DMSO (10 µL, 10 µmol nitroalkane). Next, 
Ser (10 µmol) was added as a solution in 170 µL of potassium phosphate buffer (50 mM). Finally, 20 µL of heat-
treated lysate was added (2×10–3 µmol), then the reaction was heated to 50 °C. After 12 hours, the reaction was 
chilled in ice, then diluted with 800 µL of 1:1 CH3CN/H2O. The reaction mixture was centrifuged at 20,000×g and 4 
°C (10 minutes), then the supernatant was analyzed by HPLC with a C-18 silica column (1.8 µm, 2.1 × 50 mm) 
using acetonitrile/water (0.1% acetic acid by volume): 5% to 95% acetonitrile over 4 min; 1 mL/min. The amount of 
product was calculated from the integration of the product signal in the diode array according to a calibration curve 
that used chromatographically purified material. Turnover is the theoretical maximum turnovers (5,000) multiplied 
by the fraction of product formed relative to theoretical maximum (10 µmol). At least three replicates were 
performed to validate each result. 
 
2.7 Small-scale reactions with purified protein 
A 2-mL HPLC vial was charged with nitroalkane as a 1 M solution in DMSO (10 µL, 10 µmol nitroalkane). Next, 
Ser (10 µmol) was added as a solution in 174 µL of potassium phosphate buffer (50 mM). Finally, 15 µL of purified 
protein solution was added (concentration was adjusted depending on the desired catalyst loading). The reaction was 
then heated to 50 °C in a water bath. After 12 hours, the reaction was diluted with 1:1 CH3CN/H2O (800 µL) and 
then centrifuged at 20,000×g (10 minutes, 4 °C). Finally, the supernatant was analyzed by UHPLC/MS according to 
the procedure in Section 2.6. 
 
2.8 Relative initial reaction rates at different pH 
Reaction buffers at different pH were prepared by mixing different amounts of dibasic and monobasic potassium 
phosphate buffers (50 mM). Reactions were run and analyzed using purified protein according to the procedure in 
Section 2.7 (final enzyme concentration 10 µM), except with a reaction time of ~15 minutes. The rates were 
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expressed relative to the rate at pH 6 by dividing the integration of the product signal in the diode array by the 
analogous signal for reactions at pH 6. Three replicates were performed for each reaction condition. 
 
Table S1. Integration of signal corresponding to product 3a at different pH (short reaction times) 
pH 
254 nm 230 nm 280 nm 
#1 #2 #3 #1 #2 #3 #1 #2 #3 
6.0 165 162 80.0 379 368 174 93.6 91.0 42.2 
6.5 227 205 99.1 515 459 213 127 116 52.9 
7.0 257 240 129 601 546 279 148 135 68.7 
7.5 245 248 131 556 569 283 139 140 69.8 
8.0 231 244 134 531 552 288 133 138 71.1 
8.5 249 248 135 577 557 286 143 140 71.6 
9.0 254 244 138 585 560 294 144 139 74.2 
 
Table S2. Data from Table S1 normalized to corresponding value at pH 6.0 
pH 
254 nm 230 nm 280 nm 
#1 #2 #3 #1 #2 #3 #1 #2 #3 
6.0 1 1 1 1 1 1 1 1 1 
6.5 1.38 1.27 1.24 1.36 1.25 1.23 1.36 1.27 1.25 
7.0 1.56 1.48 1.61 1.59 1.48 1.61 1.58 1.48 1.63 
7.5 1.49 1.53 1.63 1.47 1.55 1.63 1.49 1.54 1.65 
8.0 1.41 1.51 1.67 1.40 1.50 1.66 1.42 1.52 1.68 
8.5 1.51 1.53 1.69 1.52 1.51 1.65 1.53 1.54 1.70 
9.0 1.55 1.50 1.73 1.54 1.52 1.69 1.54 1.52 1.76 
 
Table S3. Integration of signal corresponding to product 3b at different pH (short reaction times) 
pH 
absorption at 230 nm 
#1 #2 #3 
6.0 5.0 4.8 6.2 
6.5 13 10 12 
7.0 15 12 15 
7.5 21 20 17 
8.0 23 22 19 
8.5 21 23 18 
9.0 24 22 19 
 
pH 
normalized 
#1 #2 #3 
6.0 1 1 1 
6.5 2.5 2.1 2.0 
7.0 3.0 2.5 2.5 
7.5 4.1 4.1 2.7 
8.0 4.5 4.6 3.1 
8.5 4.3 4.9 3.0 
9.0 4.7 4.6 3.0 
 
Table S4. Average relative rates for formation of products 3a and 3b at different pH 
Product 3a 
pH average standard deviation 
6.0 1 – 
6.5 1.29 0.06 
7.0 1.56 0.06 
7.5 1.55 0.07 
8.0 1.53 0.11 
8.5 1.58 0.07 
9.0 1.60 0.09 
 
Product 3b 
pH average standard deviation 
6.0 1.0 – 
6.5 2.2 0.2 
7.0 2.7 0.2 
7.5 3.6 0.6 
8.0 4.1 0.7 
8.5 4.0 0.8 
9.0 4.1 0.8 
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2.9 Production of products 3a and 3b at different pH (12 hours) 
Reaction buffers at different pH were prepared by mixing dibasic and monobasic potassium phosphate buffers (50 
mM). Reactions were run according to the procedure described in Section 2.7 (final enzyme concentration 10 µM). 
Three replicates were performed for each reaction condition. 
 
Table S5. Turnovers to product in 12 hours at different pH 
Product 3a 
pH #1 #2 #3 average std. dev. 
6.5 1213 1758 1855 1609 282 
7.0 2537 2846 2768 2717 131 
7.5 3098 3012 3335 3148 137 
8.0 3101 3326 3509 3312 167 
8.5 3894 4276 4223 4131 169 
9.0 3885 4035 4063 3994 78 
 
Product 3b 
pH #1 #2 #3 average std. dev. 
6.0 1354 1254 1211 1273 60 
6.5 1985 1766 1746 1832 108 
7.0 2552 2278 2300 2377 124 
7.5 2800 2675 2649 2708 66 
8.0 2857 2559 2564 2660 139 
8.5 2821 2821 2843 2828 11 
9.0 3366 2780 2731 2959 288 
 
 
Table S6. Integration of signal corresponding to hydrolysis byproduct 4 
pH 
254 nm 280 nm 
#1 #2 #3 #1 #2 #3 
6.0 1784 1678 1462 217 203 178 
6.5 1223 1234 1684 146 148 203 
7.0 1082 1050 1241 129 126 150 
7.5 861 917 981 103 109 118 
8.0 879 853 964 104 102 116 
8.5 554 550 599 70 69 76 
9.0 554 560 658 70 70 83 
 
Table S7. Data from Table S6 normalized to results at pH 9 
pH 
254 nm 280 nm 
average 
standard 
deviation #1 #2 #3 #1 #2 #3 
6.0 3.22 2.99 2.22 3.09 2.92 2.15 2.76 0.42 
6.5 2.21 2.20 2.56 2.08 2.12 2.44 2.27 0.17 
7.0 1.95 1.87 1.89 1.83 1.81 1.80 1.86 0.05 
7.5 1.55 1.64 1.49 1.46 1.56 1.42 1.52 0.07 
8.0 1.59 1.52 1.47 1.48 1.46 1.39 1.49 0.06 
8.5 1.00 0.98 0.91 1.00 0.99 0.91 0.96 0.04 
9.0 1 1 1 1 1 1 1 – 
 
2.10 Turnover frequency with substrates 2a, 2b, and indole 
Reactions were performed in pH 9.0 potassium phosphate buffer according to the procedure detailed in Section 
2.7, except with reaction times of 15 minutes using substrate 2a or indole and 45 minutes using substrate 2b. The 
rates were expressed as turnovers per minute by dividing the number of turnovers by the reaction time. Three 
replicates were performed for each reaction condition. 
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Table S8. Turnover frequency (min–1) to products 3a and 3b (short reaction time) 
Product 3a 
variant #1 #2 #3 avg. std. dev. 
Pf(β-Me) 3.56 3.12 2.53 3.07 0.42 
Pf(NMB) 30.16 29.70 29.09 29.65 0.44 
 
Product 3b 
variant #1 #2 #3 avg. std. dev. 
Pf(β-Me) 0.42 0.42 0.44 0.43 0.01 
Pf(NC) 8.72 8.95 9.09 8.92 0.15 
 
 
Table S9. Turnover frequency (min–1) to tryptophan (short reaction time) 
Tryptophan 
variant #1 #2 #3 avg. std. dev. 
Pf(β-Me) 33 34 34 33.5 0.5 
Pf(NMB) 83 79 85 82 3 
Pf(NC) 57 63 64 62 3 
 
2.11 Activity with other nitroalkane substrates (Chart 1) 
Reactions with other nitroalkane substrates were performed in pH 9.0 potassium phosphate buffer according to the 
procedure detailed in Section 2.7 (final enzyme concentration 10 µM). For each substrate, individual reactions with 
Pf(β-Me), Pf(NMB), and Pf(NC) were run to determine which catalyst provided the highest activity. Then, reactions 
with the best catalyst were run in triplicate, and the product formation was determined by HPLC (diode array 
detector). For products 3c–e, purified product was used to calibrate HPLC signal to product formation. For products 
3f–h, the product yield was estimated by comparing the integration of the product signal to that of the starting 
material signal. For product 3i, the HPLC signal was calibrated using purified product 3a. 
 
Table S10. Turnovers to other amino acid products in 12 hours 
product variant #1 #2 #3 avg. std. dev. 
3c Pf(NC) 1541 1414 1608 1521 80 
3d Pf(NMB) 1232 1222 1199 1217 14 
3e Pf(NC) 966 905 972 947 30 
3f Pf(NC) 453 455 478 462 11 
 
3. Synthesis and characterization of noncanonical amino acid products 
3.1 General information for biocatalytic reactions 
Proton and carbon NMR spectra were recorded either on a Bruker 400 MHz (100 MHz) spectrometer equipped 
with a cryogenic probe. Proton chemical shifts are reported in ppm (δ) relative to tetramethylsilane and calibrated 
using the residual solvent resonance (DMSO-d6, δ 2.50 ppm or D2O, δ 4.79 ppm). Data are reported as follows: 
chemical shift (multiplicity [singlet (s), doublet (d), doublet of doublets (dd), doublet of doublets of doublets (ddd), 
triplet (t), multiplet (m)], coupling constants [Hz], integration). Carbon NMR spectra were recorded with complete 
proton decoupling. Carbon chemical shifts are reported in ppm relative to tetramethylsilane and calibrated using the 
residual solvent 13C resonance (DMSO-d6, δ 39.52); for spectra in D2O, the residual solvent proton resonance was 
used as an absolute reference. All NMR spectra were recorded at ambient temperature (about 25 °C). Preparative 
reversed-phase chromatography was performed on a Biotage Isolera One purification system, using C-18 silica as 
the stationary phase, with methanol as the strong solvent and water (0.1% HCl by weight) as the weak solvent. The 
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gradient of the eluent (Ñ) is given as % strong solvent/column volume (CV). High-resolution mass spectrometry 
(HRMS) was conducted with an Agilent 6200 TOF, with samples ionized by electrospray ionization (ESI). All 
starting materials were purchased from commercial sources and used without further purification. Liquid 
chromatography/mass spectrometry (LCMS) was performed on an Agilent 1290 UPLC-LCMS equipped with a 2.1 
× 50 mm C-18 silica column, using acetonitrile as the strong solvent and 0.1% (v/v) acetic acid/water as the weak 
solvent. The optical purity of the products was determined by derivatization with N-(5-fluoro-2,4-
dinitrophenyl)alaninamide (FDNP-alaninamide) as described below. 
The substrate (nitromethyl)benzene (2a) was purchased from Sigma Aldrich and purified by flash 
chromatography (silica, 1–5% ethyl acetate/hexanes). The substrates nitrocyclohexane (2b) and nitrocyclopentane 
(2c) were purchased from Sigma Aldrich and used as received. Substrates 2d–h were prepared according to the 
procedure of Kozlowski and co-workers.4 Substrate 2i was prepared according to the procedure of Tomaselli and co-
workers.5 An authentic standard of (S)-5 was purchased from Chem-Impex. 
 
3.2 Preparative reactions for product characterization 
Reactions were conducted using up to 1 mmol of substrate. A 20-mL reaction vial with stir bar was charged with 
nitroalkane, followed by a solution of serine in potassium phosphate buffer (50 mM, pH 9), such that the nitroalkane 
and serine both had a final concentration of 50 mM (for substrates 2d-f, 5% v/v DMSO was used as a co-solvent). 
The corresponding enzyme (see Chart 1) was prepared as heat-treated lysate and added to achieve a final enzyme 
concentration of 0.010 mM. The reaction vessel was sealed, and then heated to 50 °C with gentle stirring (300 rpm). 
After 12 hours, the reaction was purified directly by C-18 silica (see below).  
For products 3b-c, the reaction mixture was injected directly onto C-18 silica, eluting with methanol/water 
(typical gradient: 1 column volume of 1% methanol/water, then 1–100% methanol/water over 10 column volumes). 
After lyophilization, the products were obtained as the free base. 
The other products can exist as the nitro or aci-nitro tautomers (see Figure 1b). To isolate the compounds in the 
nitro form, the reaction mixtures were first acidified to pH < 3 with 0.1% w/w aqueous HCl. This mixture was 
injected directly onto C-18 silica, and then the product was eluted as the nitro tautomer using a gradient of 1–100% 
methanol/water (0.1% w/w HCl) over 10 column volumes. Following lyophilization, the product was obtained as the 
hydrochloride salt. 
 
3.3 Determination of optical purity 
FDNP-alaninamide was used as a solution in acetone (33 mM). In a 2-mL vial, the amino acid (0.50 µmol) was 
dissolved in 1 M aq. NaHCO3 (100 µL). FDNP-alaninamide (10 µL, 0.33 µmol) was added, then the vial was placed 
in an incubator at 37 °C and shaken at 230 rpm. After 2 h, the reaction mixture was allowed to cool to room 
temperature, then diluted with 1:1 CH3CN/H2O (600 µL). The resulting solution was analyzed directly by LCMS 
(5% to 95% acetonitrile, Figure S3). Each amino acid was derivatized with both racemic and enantiopure FDNP-
alaninamide. The epimerizable compounds 3a and 3d–g could not be analyzed directly, so compound 3a was first 
converted to compound 5 (see Section 3.6), while compounds 3d–g were hydrolyzed to the ketone derivatives. 
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Figure S3. HPLC traces of products derivatized with FDNP-L-alaninamide and FDNP-DL-alaninamde. 
 
3.4 Determination of absolute stereochemistry 
Purified product 3a was converted to compound 5 according to the procedure in Section 3.6. This compound was 
then derivatized with FDNP-alaninamide (see Section 3.3). Separately, an authentic sample of (S)-5 was derivatized 
with FDNP-alaninamide by an identical procedure. Comparison of the derivatized compounds by LCMS confirmed 
that the synthetic compound 5 and, by extension, compounds 3a and 4 all had the S configuration in the major 
enantiomer (Figure S3). In addition, the specific rotation of synthetic compound 5•HCl in 3 M aq. HCl ([α]D = 
+35.516 at 24.8 °C) corresponds closely to the reported value.6 The major enantiomers of the other products were 
inferred to have the S configuration by analogy. Notably, the same absolute configuration is favored in the native 
reaction of the wild-type enzyme. Furthermore, for all products derivatized with FDNP-alaninamide, the major 
enantiomer eluted first; although there is no strict correlation between elution order on HPLC and absolute 
configuration, it was observed that L-amino acids derivatized with FDNP-alaninamide tend to elute earlier than their 
D enantiomers.7 
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Figure S4. HPLC traces (absorption at 254 nm) of (a) synthetic product 5 tagged with FDNP-L-alaninamide, (b) 
synthetic product 5 tagged with FDNP-DL-alaninamide, (c) authentic (S)-5 tagged with FDNP-L-alaninamide, and 
(d) authentic (S)-5 tagged with FDNP-DL-alaninamide. 
 
3.5 Hydrolysis of product 3a to ketone 4 
In a 5-mL reaction vial with a stir bar, product 3a (26 mg, 100 µmol) was suspended in water (1000 µL) and 
stirred vigorously at 24 °C. After 24 h, the product was purified directly by C-18 silica, eluting with methanol and 
0.1% w/w aqueous HCl (1 CV of 1% methanol, then 1–100% methanol over 10 CV). The hydrochloride salt of the 
product was obtained as a white solid (14 mg, 61% yield). 
 
3.6 Denitration of product 3a to product 5 
In a 5-mL reaction vial with stir bar, product 3a (20.7 mg, 92 µmol) was dissolved in 1:1 ethanol/water (1 mL). 
Pd(OH)2/C (3.2 mg, 20% w/w, 4.6 µmol) was added. The vessel head-space was flushed with a hydrogen balloon, 
and then put under static hydrogen pressure (1 bar). The reaction was heated to 65 °C with vigorous stirring. After 
12 hours, the reaction was allowed to cool to ambient temperature. The ethanol was removed in vacuo, and then the 
residue was dissolved in 1 M aq. HCl and purified directly by C-18 silica (10 column volumes of 1% 
methanol/water, then 1–100% methanol/water over 10 column volumes). Fractions containing the product were 
concentrated in vacuo, and then the residue was dissolved in 1 M aq. HCl and transferred to a vial. After 
lyophilization, the product was obtained as a white solid (18.3 mg, 91% yield of the hydrochloride salt). 
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3.7 Characterization of isolated amino acids 
Compound 3a (HCl salt). The product was obtained as a 3:2 mixture of diastereomers. Major 
diastereomer: 1H NMR (400 MHz, DMSO-d6) δ 8.69 (s, 3H), 7.60–7.44 (m, 5H), 6.19 (dd, J = 8.4, 
5.7 Hz, 1H), 3.74 (t, J = 7.1 Hz, 1H), 3.10 (dt, J = 14.7, 8.0 Hz, 1H), 2.57 (dt, J = 14.8, 6.3 Hz, 1H). 
13C NMR (100 MHz) δ 169.8, 134.6, 130.0, 129.2, 127.7, 86.4, 49.6, 33.2. Minor diastereomer: 1H 
NMR (400 MHz, DMSO-d6) δ 8.69 (s, 3H), 7.60–7.44 (m, 5H), 6.27 (t, J = 7.3 Hz, 1H), 3.61 (t, J = 6.6 Hz, 1H), 
3.00 (dt, J = 14.8, 7.3 Hz, 1H), 2.65 (dt, J = 15.0, 6.8 Hz, 1H). 13C NMR (100 MHz) δ 169.7, 134.1, 130.2, 129.3, 
127.9, 85.9, 49.2, 33.5. HRMS (ESI) (m/z) for [M+H]+ (C10H13N2O4) calculated 225.0870, observed 225.0866. ee 
97%. 
 
Compound 3b (free base). 1H NMR (400 MHz, DMSO-d6) δ 7.45 (s, 2H), 3.08 (dd, J = 7.2, 4.4 Hz, 
1H), 2.27 (ABX, JAX = 7.3 Hz, JBX = 4.4 Hz, JAB = 15.2 Hz, νAB = 223.4 Hz, 2H), 2.34–2.25 (m, 2H), 
1.86–1.66 (m, 2H), 1.63–1.53 (m, 2H), 1.53–1.45 (m, 1H), 1.35–1.15 (m, 3H). 13C NMR (100 MHz) 
δ 169.5, 90.8, 49.9, 33.3, 32.7, 23.9, 21.9, 21.9. HRMS (ESI) (m/z) for [M+H]+ (C9H17N2O4) calculated 217.1110, 
observed 217.1182. ee >99%. 
 
Compound 3c (free base). 1H NMR (400 MHz, DMSO-d6) δ 7.40 (s, 2H), 3.07 (t, J = 6.2 Hz, 1H), 
2.47–2.35 (m, 2H), 2.42 (ABX, JAX = 7.0 Hz, JBX = 5.4 Hz, JAB = 15.1 Hz, νAB = 181.2 Hz, 2H), 
2.02–1.87 (m, 2H), 1.76–1.57 (m, 4H). 13C NMR (100 MHz) δ 169.8, 98.3, 51.1, 37.0, 36.6, 23.8, 
23.6. HRMS (ESI) (m/z) for [M+H]+ (C8H15N2O4) calculated 203.1026, observed 203.1019. ee 98%. 
 
Compound 3d (HCl salt). The product was obtained as a 2:1 mixture of diastereomers. Major 
diastereomer: 1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 3H), 7.46–7.25 (m, 4H), 6.31 (dd, J = 8.5, 
6.0 Hz, 1H), 3.76 (t, J = 6.9 Hz, 1H), 3.14–3.05 (m, 1H), 2.61–2.49 (m, 1H), 2.48 (s, 3H). 13C NMR 
(100 MHz) δ 169.8, 137.4, 132.9, 131.1, 129.8, 126.9, 126.0, 82.5, 49.6, 32.8, 19.0. Minor 
diastereomer: 1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 3H), 7.39–7.25 (m, 4H), 6.34 (dd, J = 9.0, 4.8 Hz, 1H), 
3.89 (dd, J = 7.6, 4.9 Hz, 1H), 3.07–2.99 (m, 1H), 2.61–2.49 (m, 1H), 2.44 (s, 3H). 13C NMR (100 MHz) δ 169.8, 
137.0, 132.9, 131.1, 129.8, 127.0, 125.9, 82.6, 49.2, 32.9, 18.9. HRMS (ESI) (m/z) for [M+H]+ (C11H15N2O4) 
calculated 239.1026, observed 239.1031. ee 92%. 
 
Compound 3e. HRMS (ESI) (m/z) for [M+H]+ (C14H15N2O4) calculated 275.1026, observed 
275.1028. ee 61%. 
 
For characterization by NMR, the compound was converted to the ketone (HCl salt). 1H NMR 
(400 MHz, D2O) δ 8.60 (d, J = 1.7 Hz, 1H), 8.06 (d, J = 8.1 Hz, 1H), 8.02–7.93 (m, 3H), 7.70 
(ddd, J = 8.3, 6.9, 1.4 Hz, 1H), 7.64 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 4.55 (t, J = 5.1 Hz, 1H), 
4.01 (d, J = 5.1 Hz, 2H). 13C NMR (100 MHz, D2O) δ 199.0, 171.8, 135.9, 132.3, 132.1, 131.1, 
129.8, 129.5, 128.7, 127.8, 127.4, 123.0, 49.1, 38.2. 
 
Compound 3f (HCl salt). The product was obtained as a 3:2 mixture of diastereomers.Major 
diastereomer: 1H NMR (400 MHz, DMSO-d6) δ 8.69 (s, 3H), 8.03 (d, J = 8.3 Hz, 2H), 7.68 
(d, J = 8.4 Hz, 2H), 6.32 (dd, J = 8.4, 5.5 Hz, 1H), 4.33 (q, J = 7.1 Hz, 2H), 3.84 (t, J = 7.0 
Hz, 1H), 3.14 (dt, J = 15.3, 7.9 Hz, 1H), 2.58 (dt, J = 14.7, 6.1 Hz, 1H), 1.32 (t, J = 7.1 Hz, 
3H). 13C NMR (100 MHz, DMSO-d6) δ 169.7, 165.1, 139.1, 131.2, 129.9, 128.3, 85.7, 61.1, 49.5, 33.1, 14.2. Minor 
diastereomer: 1H NMR (400 MHz, DMSO-d6) δ 8.69 (s, 3H), 8.05 (d, J = 8.3 Hz, 2H), 7.73 (d, J = 8.4 Hz, 2H), 6.38 
(t, J = 7.1 Hz, 1H), 4.33 (q, J = 7.1 Hz, 2H), 3.69 (t, J = 6.4 Hz, 1H), 3.04 (dt, J = 14.6, 7.2 Hz, 1H), 2.69 (dt, J = 
14.9, 6.6 Hz, 1H), 1.32 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ 169.6, 165.1, 138.7, 131.4, 130.0, 
128.5, 85.3, 61.1, 49.0, 33.4, 14.2. HRMS (ESI) (m/z) for [M+H]+ (C13H17N2O6) calculated 297.1081, observed 
297.1087. ee 81%. 
 
Compound 4 (HCl salt). 1H NMR (400 MHz, D2O) δ 8.07–7.99 (m, 2H), 7.74 (ddt, J = 8.7, 7.0, 
1.3 Hz, 1H), 7.64–7.54 (m, 2H), 4.48 (t, J = 5.2 Hz, 1H), 3.90 (d, J = 5.2 Hz, 2H). 13C NMR (100 
MHz, D2O) δ 199.5, 172.1, 135.0, 134.8, 129.0, 128.3, 49.2, 38.3. HRMS (ESI) (m/z) for [M+H]+ 
(C10H12NO3) calculated 194.0812, observed 194.0803. ee 95%. 
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Compound 5. 1H NMR (400 MHz, D2O/NaOD) δ 7.10–7.03 (m, 2H), 7.03–6.93 (m, 3H), 2.94 (dd, 
J = 7.0, 5.7 Hz, 1H), 2.33 (t, J = 8.2 Hz, 1H), 1.64–1.56 (m, 1H), 1.56–1.45 (m, 1H). 13C NMR 
(100 MHz, D2O) δ 183.2, 142.1, 128.6, 128.4, 128.2, 55.6, 36.7, 31.3. HRMS (ESI) (m/z) for 
[M+H]+ (C10H14NO2) calculated 180.1019, observed 180.1019. [α]D of 5•HCl in 3 M aq. HCl at 
24.8 °C, +35.516°. ee 97%. 
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